Next-generation drug-eluting stents: a spirited step forward or more of the same
- PMID: 18430915
- DOI: 10.1001/jama.299.16.1952
Next-generation drug-eluting stents: a spirited step forward or more of the same
Comment on
-
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.JAMA. 2008 Apr 23;299(16):1903-13. doi: 10.1001/jama.299.16.1903. JAMA. 2008. PMID: 18430909 Clinical Trial.
Similar articles
-
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.JAMA. 2008 Apr 23;299(16):1903-13. doi: 10.1001/jama.299.16.1903. JAMA. 2008. PMID: 18430909 Clinical Trial.
-
Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial.Circulation. 2011 Aug 23;124(8):886-92. doi: 10.1161/CIRCULATIONAHA.110.015453. Epub 2011 Aug 1. Circulation. 2011. PMID: 21810659 Clinical Trial.
-
Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus.Circulation. 2011 Aug 23;124(8):893-900. doi: 10.1161/CIRCULATIONAHA.111.031070. Epub 2011 Aug 8. Circulation. 2011. PMID: 21824922
-
Choice of drug-eluting stents.Med Lett Drugs Ther. 2012 Dec 24;54(1406):102-3. Med Lett Drugs Ther. 2012. PMID: 23282791 Review. No abstract available.
-
New-generation drug-eluting stents: focus on Xience V® everolimus-eluting stent and Resolute® zotarolimus-eluting stent.J Interv Cardiol. 2013 Jun;26(3):278-86. doi: 10.1111/joic.12028. Epub 2013 Apr 22. J Interv Cardiol. 2013. PMID: 23607275 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
